Interaction of digoxin with antihypertensive drugs via MDR1

Kohji Takara, Mikio Kakumoto, Yusuke Tanigawara, Junko Funakoshi, Toshiyuki Sakaeda, Katsuhiko Okumura

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The multidrug transporter MDR1 (P-glycoprotein)-mediated interaction between digoxin and 29 antihypertensive drugs of various types was examined by using the MDR1 overexpressing LLC-GA5-COL150 cells, which were established by transfecting MDR1 cDNA into porcine kidney epithelial LLC-PK1 cells. These cells construct monolayers with tight junctions, and enable the evaluation of transcellular transport. The MDR1 was highly expressed on the apical membrane (urine side). The basal-to-apical and apical-to-basal transcellular transport of [3H]digoxin in LLC-GA5-COL150 cells was time- and temperature-dependent. The basal-to-apical transport of [3H]digoxin was markedly increased, whereas the apical-to-basal transport was decreased in LLC-GA5-COL150 cells, compared with the host LLC-PK1 cells, suggesting that [3H]digoxin was a substrate for MDR1. Most of the Ca2+ channel blockers used here markedly inhibited basal-to-apical transport and increased apical-to-basal transport. Exceptions were diltiazem, nifedipine and nitrendipine, which hardly showed inhibitory effects on transcellular transport of [3H]digoxin. α-Blocker doxazosin and β-blocker carvedilol also inhibited transcellular transport of [3H]digoxin, but none of the angiotensin converting enzyme inhibitors and AT1 angiotensin II receptor antagonists used here were active. These observations will promote understanding of the digoxin-drug interactions resulting from their actions on MDR1, and which may aid in avoiding these unexpected effects of digoxin.

Original languageEnglish
Pages (from-to)1491-1500
Number of pages10
JournalLife Sciences
Volume70
Issue number13
DOIs
Publication statusPublished - 2002 Feb 15

Fingerprint

Digoxin
Antihypertensive Agents
Transcytosis
LLC-PK1 Cells
Drug interactions
Doxazosin
Nitrendipine
Diltiazem
Tight Junctions
Angiotensin Receptor Antagonists
P-Glycoprotein
Nifedipine
Drug Interactions
Angiotensin-Converting Enzyme Inhibitors
Monolayers
Swine
Complementary DNA
Epithelial Cells
Urine
Membranes

Keywords

  • Antihypertensive drugs
  • Digoxin
  • Drug interactions
  • MDR1
  • P-glycoprotein
  • Transcellular transport

ASJC Scopus subject areas

  • Pharmacology

Cite this

Takara, K., Kakumoto, M., Tanigawara, Y., Funakoshi, J., Sakaeda, T., & Okumura, K. (2002). Interaction of digoxin with antihypertensive drugs via MDR1. Life Sciences, 70(13), 1491-1500. https://doi.org/10.1016/S0024-3205(01)01494-1

Interaction of digoxin with antihypertensive drugs via MDR1. / Takara, Kohji; Kakumoto, Mikio; Tanigawara, Yusuke; Funakoshi, Junko; Sakaeda, Toshiyuki; Okumura, Katsuhiko.

In: Life Sciences, Vol. 70, No. 13, 15.02.2002, p. 1491-1500.

Research output: Contribution to journalArticle

Takara, K, Kakumoto, M, Tanigawara, Y, Funakoshi, J, Sakaeda, T & Okumura, K 2002, 'Interaction of digoxin with antihypertensive drugs via MDR1', Life Sciences, vol. 70, no. 13, pp. 1491-1500. https://doi.org/10.1016/S0024-3205(01)01494-1
Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K. Interaction of digoxin with antihypertensive drugs via MDR1. Life Sciences. 2002 Feb 15;70(13):1491-1500. https://doi.org/10.1016/S0024-3205(01)01494-1
Takara, Kohji ; Kakumoto, Mikio ; Tanigawara, Yusuke ; Funakoshi, Junko ; Sakaeda, Toshiyuki ; Okumura, Katsuhiko. / Interaction of digoxin with antihypertensive drugs via MDR1. In: Life Sciences. 2002 ; Vol. 70, No. 13. pp. 1491-1500.
@article{af96225e64f84561ac2e43c090ee84f7,
title = "Interaction of digoxin with antihypertensive drugs via MDR1",
abstract = "The multidrug transporter MDR1 (P-glycoprotein)-mediated interaction between digoxin and 29 antihypertensive drugs of various types was examined by using the MDR1 overexpressing LLC-GA5-COL150 cells, which were established by transfecting MDR1 cDNA into porcine kidney epithelial LLC-PK1 cells. These cells construct monolayers with tight junctions, and enable the evaluation of transcellular transport. The MDR1 was highly expressed on the apical membrane (urine side). The basal-to-apical and apical-to-basal transcellular transport of [3H]digoxin in LLC-GA5-COL150 cells was time- and temperature-dependent. The basal-to-apical transport of [3H]digoxin was markedly increased, whereas the apical-to-basal transport was decreased in LLC-GA5-COL150 cells, compared with the host LLC-PK1 cells, suggesting that [3H]digoxin was a substrate for MDR1. Most of the Ca2+ channel blockers used here markedly inhibited basal-to-apical transport and increased apical-to-basal transport. Exceptions were diltiazem, nifedipine and nitrendipine, which hardly showed inhibitory effects on transcellular transport of [3H]digoxin. α-Blocker doxazosin and β-blocker carvedilol also inhibited transcellular transport of [3H]digoxin, but none of the angiotensin converting enzyme inhibitors and AT1 angiotensin II receptor antagonists used here were active. These observations will promote understanding of the digoxin-drug interactions resulting from their actions on MDR1, and which may aid in avoiding these unexpected effects of digoxin.",
keywords = "Antihypertensive drugs, Digoxin, Drug interactions, MDR1, P-glycoprotein, Transcellular transport",
author = "Kohji Takara and Mikio Kakumoto and Yusuke Tanigawara and Junko Funakoshi and Toshiyuki Sakaeda and Katsuhiko Okumura",
year = "2002",
month = "2",
day = "15",
doi = "10.1016/S0024-3205(01)01494-1",
language = "English",
volume = "70",
pages = "1491--1500",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "13",

}

TY - JOUR

T1 - Interaction of digoxin with antihypertensive drugs via MDR1

AU - Takara, Kohji

AU - Kakumoto, Mikio

AU - Tanigawara, Yusuke

AU - Funakoshi, Junko

AU - Sakaeda, Toshiyuki

AU - Okumura, Katsuhiko

PY - 2002/2/15

Y1 - 2002/2/15

N2 - The multidrug transporter MDR1 (P-glycoprotein)-mediated interaction between digoxin and 29 antihypertensive drugs of various types was examined by using the MDR1 overexpressing LLC-GA5-COL150 cells, which were established by transfecting MDR1 cDNA into porcine kidney epithelial LLC-PK1 cells. These cells construct monolayers with tight junctions, and enable the evaluation of transcellular transport. The MDR1 was highly expressed on the apical membrane (urine side). The basal-to-apical and apical-to-basal transcellular transport of [3H]digoxin in LLC-GA5-COL150 cells was time- and temperature-dependent. The basal-to-apical transport of [3H]digoxin was markedly increased, whereas the apical-to-basal transport was decreased in LLC-GA5-COL150 cells, compared with the host LLC-PK1 cells, suggesting that [3H]digoxin was a substrate for MDR1. Most of the Ca2+ channel blockers used here markedly inhibited basal-to-apical transport and increased apical-to-basal transport. Exceptions were diltiazem, nifedipine and nitrendipine, which hardly showed inhibitory effects on transcellular transport of [3H]digoxin. α-Blocker doxazosin and β-blocker carvedilol also inhibited transcellular transport of [3H]digoxin, but none of the angiotensin converting enzyme inhibitors and AT1 angiotensin II receptor antagonists used here were active. These observations will promote understanding of the digoxin-drug interactions resulting from their actions on MDR1, and which may aid in avoiding these unexpected effects of digoxin.

AB - The multidrug transporter MDR1 (P-glycoprotein)-mediated interaction between digoxin and 29 antihypertensive drugs of various types was examined by using the MDR1 overexpressing LLC-GA5-COL150 cells, which were established by transfecting MDR1 cDNA into porcine kidney epithelial LLC-PK1 cells. These cells construct monolayers with tight junctions, and enable the evaluation of transcellular transport. The MDR1 was highly expressed on the apical membrane (urine side). The basal-to-apical and apical-to-basal transcellular transport of [3H]digoxin in LLC-GA5-COL150 cells was time- and temperature-dependent. The basal-to-apical transport of [3H]digoxin was markedly increased, whereas the apical-to-basal transport was decreased in LLC-GA5-COL150 cells, compared with the host LLC-PK1 cells, suggesting that [3H]digoxin was a substrate for MDR1. Most of the Ca2+ channel blockers used here markedly inhibited basal-to-apical transport and increased apical-to-basal transport. Exceptions were diltiazem, nifedipine and nitrendipine, which hardly showed inhibitory effects on transcellular transport of [3H]digoxin. α-Blocker doxazosin and β-blocker carvedilol also inhibited transcellular transport of [3H]digoxin, but none of the angiotensin converting enzyme inhibitors and AT1 angiotensin II receptor antagonists used here were active. These observations will promote understanding of the digoxin-drug interactions resulting from their actions on MDR1, and which may aid in avoiding these unexpected effects of digoxin.

KW - Antihypertensive drugs

KW - Digoxin

KW - Drug interactions

KW - MDR1

KW - P-glycoprotein

KW - Transcellular transport

UR - http://www.scopus.com/inward/record.url?scp=0037083941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037083941&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(01)01494-1

DO - 10.1016/S0024-3205(01)01494-1

M3 - Article

VL - 70

SP - 1491

EP - 1500

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 13

ER -